CLCA4_Clac4 Inhibitors represent a specialized class of chemical compounds designed to selectively hinder the activity of the CLCA4 (Chloride Channel Accessory 4) or Clac4 protein. CLCA4 belongs to the calcium-activated chloride channel regulators, a group of proteins implicated in the modulation of chloride transport across cell membranes. The development of inhibitors targeting CLCA4_Clac4 is integral to scientific inquiry, serving as specific tools for unraveling the molecular functions and regulatory roles associated with this particular protein. As part of the chloride channel regulatory family, CLCA4_Clac4 likely plays a role in modulating ion flux across cellular membranes, influencing cellular excitability and secretory functions.
The synthesis and refinement of CLCA4_Clac4 inhibitors require a thorough understanding of the protein's structural characteristics and its interactions within cellular contexts. These inhibitors are meticulously crafted for specificity, designed to selectively bind to key regions of CLCA4_Clac4 and interfere with its normal regulatory functions. By employing these inhibitory compounds in experimental settings, researchers can investigate the consequences of CLCA4_Clac4 inhibition on cellular ion homeostasis, shedding light on the protein's potential contributions to cellular physiology. The study of CLCA4_Clac4 inhibitors contributes to the broader exploration of ion channel regulation, providing insights into the intricate molecular mechanisms that govern cellular responses to changes in chloride concentrations and supporting a deeper comprehension of the diverse functions associated with this particular class of proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil interferes with RNA synthesis, affecting the expression of chloride channel accessory 4 (CLCA4). | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA, inhibiting transcription and reducing the synthesis of CLCA4. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis, leading to a decrease in CLCA4 levels. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin induces premature termination of protein synthesis, contributing to the downregulation of CLCA4 expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase, indirectly suppressing CLCA4 expression by affecting transcription processes. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin blocks peptidyl transferase activity, inhibiting protein synthesis and reducing the levels of CLCA4. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin interferes with mRNA synthesis, impacting transcription and subsequently decreasing the expression of CLCA4. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, indirectly affecting CLCA4 expression by disrupting purine synthesis. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $367.00 $520.00 | 20 | |
Blasticidin S induces premature termination during translation, inhibiting protein synthesis and reducing the synthesis of CLCA4. | ||||||